Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Lexington › NPI 1679520258
Hospital

Midwest Division - LRHC LLC

Midwest Division - LRHC LLC was paid $6.41M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.

33Billing provider infoMIDWEST DIVISION - LRHC LLC
LEXINGTON, MO 64067
33aNPI1679520258assigned 05/28/2006
33bProvider typeCritical Access Hospital
28Total paid$6.41M
24GClaims61,807
24DCodes billed54
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Critical Access Hospital providers in Missouri

Rank by total paid#8 of 33
Median peer was paid$2.24M
This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812,811$1.68M
20199,592$1.55M
20204,334$480K
20217,736$335K
20229,272$638K
202311,632$1.01M
2024incomplete6,430$717K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 30% 9,670 9,075 $1.91M
X4011 State-specific procedure code 16% 3,361 2,357 $1.06M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 3,273 2,987 $846K
85027 8.1% 9,029 6,817 $516K
80053 Comprehensive metabolic panel 7.5% 8,314 6,307 $478K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3.3% 2,188 1,874 $212K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.7% 1,001 921 $175K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.8% 423 357 $118K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 1,922 1,447 $115K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 931 833 $106K
87430 1.3% 1,069 1,039 $84K
87081 <1% 589 574 $62K
42 more codes
36415 Collection of venous blood by venipuncture <1% 4,909 $55K
81003 <1% 585 $52K
85610 <1% 714 $47K
X4006 <1% 86 $42K
G0378 Hospital observation service, per hour <1% 145 $40K
84484 <1% 1,257 $38K
71046 Radiologic examination, chest; 2 views <1% 154 $37K
87428 <1% 1,491 $35K
83880 <1% 802 $34K
71045 Radiologic examination, chest; single view <1% 635 $31K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 124 $31K
85730 <1% 480 $26K
70450 Computed tomography, head or brain; without contrast material <1% 176 $25K
86140 <1% 331 $25K
X4003 <1% 751 $19K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 194 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 295 $18K
83690 <1% 411 $17K
81001 <1% 385 $15K
71250 <1% 103 $15K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 165 $14K
J3490 Unclassified drugs <1% 3,077 $12K
20610 <1% 41 $9K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 299 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 67 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 694 $6K
83605 <1% 69 $6K
62323 <1% 12 $6K
80306 <1% 97 $6K
82550 <1% 228 $5K
87807 <1% 46 $5K
82553 <1% 201 $4K
83735 <1% 157 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 248 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 169 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 29 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 25 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 57 $1K
87070 <1% 31 $283.82
81002 <1% 229 $276.46
87040 <1% 54 $172.71
84703 <1% 14 $98.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJAMES, TERI (CFO)